Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5
Clinical trial NCT00761449 · COMPLETED
Trial details
- NCT number
- NCT00761449
- Sponsor
- Nordic MDS Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.